The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.80
Bid: 12.10
Ask: 13.00
Change: 0.05 (0.43%)
Spread: 0.90 (7.438%)
Open: 12.50
High: 12.50
Low: 11.80
Prev. Close: 11.75
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

31 Aug 2023 07:00

RNS Number : 8613K
Carclo plc
31 August 2023
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

31 August 2023

 

Carclo plc

 

("Carclo" or the "Group")

 

Trading Update

 

 

Carclo plc, the leading global provider of high-precision components, offering comprehensive services from mould design, automation, and production to assembly and printing, serving the life sciences, aerospace, optics, and tech sectors, announces a trading update.

Our CTP Design & Engineering business has showcased remarkable resilience and growth, with sales figures exceeding expectations year to date. The order book remains robust, reflecting the trust our clients place in our capabilities and the market's recognition of our advanced solutions. This strong position underscores our commitment to innovation and our ability to meet the evolving needs of our clients, further solidifying Carclo's reputation as a leader in the sector.

In our CTP US Manufacturing Solutions business, we are navigating through a tight labour market, which has presented operational challenges across all of our US facilities. The ongoing restructuring reflects our commitment to aligning our operations more closely with market demand. While the initiation of a significant project with a major customer has seen some delays, and we've observed a softer demand in the early part of the year due to destocking at our customers, we remain optimistic about the future trajectory. Our proactive approach will ensure that we're positioned to address these short-term challenges without compromising our long-term vision.

Our CTP EMEA Manufacturing Solutions business has emerged stronger post-restructuring. The results are evident in our enhanced operational performance, allowing us to keep pace with the growth of the EMEA market. With long-run operations solidified in the UK and medium flexible runs in our Czech facility, we've achieved a harmonious blend of efficiency and flexibility. Furthermore, improvements in material utilisation underscore our commitment to operational excellence.

The Aerospace division is experiencing a notable resurgence, with indicators showing the market is rebounding to its pre-COVID vibrancy. This revival is not merely a reflection of the broader industry trend but is also a testament to our strategic and proactive business development initiatives. Through targeted efforts, we've not only captured new opportunities but also strengthened existing partnerships. These achievements, combined with our unwavering commitment to quality and innovation, have further solidified Carclo's highly-regarded position within the aerospace sector.

Financially, our focus on cash conversion and margin improvement, rather than just sales growth, is beginning to reflect positively on our balance sheet. The strategy to bolster our balance sheet's health is evident across our operations. The compensation received from the cancelled manufacturing framework agreement has been utilised to reduce our bank debt. In an environment of rising interest rates, our emphasis on cash management becomes even more pivotal.

We will provide more details when we release our interim results for the six months ending 30 September 2023 later this year.

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc 01924 268040

Frank Doorenbosch - Chief Executive Officer

Eric Hutchinson - Chief Financial Officer

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVRTDIIVIV
Date   Source Headline
10th Jul 20185:27 pmRNSForm 8.3 - [Carclo plc]
10th Jul 20184:10 pmRNSForm 8.3 - [carclo plc]
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
10th Jul 20189:57 amBUSForm 8.3 - Carclo PLC
9th Jul 20183:55 pmRNSForm 8.3 - Carclo plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
9th Jul 201810:39 amRNSForm 8.3 - Carclo plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
5th Jul 201812:09 pmRNSForm 8 (OPD) - CONSORT MEDICAL PLC
5th Jul 201812:08 pmRNSForm 8 (OPD) - Carclo plc
5th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 20183:04 pmRNSHolding(s) in Company
4th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 201810:26 amRNSForm 8.3 - Carclo plc
3rd Jul 20184:22 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20182:33 pmPRNForm 8.3 - Carclo plc
3rd Jul 20182:26 pmRNSForm 8.3 - [Carclo plc]
3rd Jul 20181:56 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20181:49 pmRNSHolding(s) in Company
3rd Jul 20181:32 pmRNSForm 8.3 - Carclo plc
3rd Jul 20181:00 pmRNSForm 8.3 - Carclo plc
3rd Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
3rd Jul 201811:36 amBUSForm 8.3 - Carclo plc - Ordinary shares
3rd Jul 201811:07 amRNSForm 8.3 - [Carclo plc]
2nd Jul 20181:07 pmRNSResponse to announcement from Consort Medical
2nd Jul 20187:00 amRNSNon-Binding Proposal for Carclo plc
28th Jun 20187:00 amRNSBoard changes
6th Jun 201810:27 amRNSHolding(s) in Company
5th Jun 20187:00 amRNSFinal Results
17th Apr 20187:00 amRNSDirectorate Change
9th Apr 20188:25 amRNSYear End Trading Update
26th Jan 20185:25 pmRNSDirector/PDMR Shareholding
24th Jan 201812:43 pmRNSDirector/PDMR Shareholding (Replacement)
24th Jan 201810:12 amRNSDirector/PDMR Shareholding
17th Jan 201811:27 amRNSHolding(s) in Company
16th Jan 201811:44 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSTrading Update and Board Changes
12th Jan 20182:55 pmRNSHolding(s) in Company
12th Jan 20181:45 pmRNSHolding(s) in Company
10th Jan 20185:01 pmRNSHolding(s) in Company
28th Nov 20175:30 pmRNSHolding(s) in Company
14th Nov 20177:00 amRNSHalf-year Report
3rd Oct 20179:42 amEQSEdison Investment Research Limited: Edison issues outlook on Carclo (CAR)
26th Sep 20171:34 pmRNSDirectorate Change
21st Sep 20172:40 pmRNSHolding(s) in Company
8th Sep 201711:44 amRNSDirector/PDMR Shareholding
8th Sep 201711:40 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.